Magnetar Financial’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Magnetar Financial’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-158,504	Closed	-$1.55M	–	1842
2022 Q2	$1.55M	Sell	158,504 -88,596	-36%	-$872K	0.02%	811
2022 Q1	$2.43M	Sell	247,100 -7,600	-3%	-$75.1K	0.03%	629
2021 Q4	$2.52M	Sell	254,700 -6,500	-2%	-$64.4K	0.03%	626
2021 Q3	$2.6M	Hold	261,200	–	–	0.03%	568
2021 Q2	$2.61M	Buy	261,200 +5,800	+2%	+$58K	0.02%	544
2021 Q1	$2.57M	Buy	+255,400	New	+$2.55M	0.02%	524

Other funds holding EBACU

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Magnetar Financial's EBACU Position: Q3 2022 in Review

Magnetar Financial sold out of European Biotech Acquisition Corp. Units (EBACU) in Q3 2022, closing a stake of 158,504 shares — an estimated $1.55M sold.

Magnetar Financial first reported a position in EBACU in Q1 2021 and held it in 6 quarters. The position peaked at $2.61M in Q2 2021. 18 funds tracked by Wall St. Rank hold EBACU as of Q3 2022.

Magnetar Financial reported no remaining European Biotech Acquisition Corp. Units position as of Q3 2022 after selling out during the quarter.
Magnetar Financial sold 158,504 European Biotech Acquisition Corp. Units shares in Q3 2022, an estimated $1.55M.
Magnetar Financial first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 6 quarters.
Magnetar Financial's European Biotech Acquisition Corp. Units position peaked at $2.61M in Q2 2021.
18 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.